Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
CC

CHARLIE CHAPMAN

BGR GOVERNMENT AFFAIRS · Washington, DC
Registered · LDAActive

Background

Career
Washington, DC · current
Government experience
Policy Advisor
HHS; Special Asst, HHS; Prof Staff Member, House Budget Committee; LA, House Budget Committee; Staff Asst, House Ways and Means Committee; Intern, House Ways and Means Committee
Covered official positions, as disclosed on federal filings

The past 12 months

Clients
32
past 12 months
Filings
38
past 12 months
Agencies contacted
SENATEHOUSE OF REPRESENTATIVESHealth & Human Services, Dept of (HHS)Centers For Medicare and Medicaid Services (CMS)White House OfficeOffice of Management & Budget (OMB)Commerce, Dept of (DOC)Food & Drug Administration (FDA)Treasury, Dept ofU.S. Trade Representative (USTR)Bureau of Industry and Security (BIS)Centers For Disease Control & Prevention (CDC)Defense, Dept of (DOD)Education, Dept ofIntl Trade Administration (ITA)Labor, Dept of (DOL)State, Dept of (DOS)

Specific issues

Provide strategic counsel and advocate on issues related to physician payment.
Medicare/Medicaid · 2026 Q3
Provide strategic guidance and advocacy on issues related to regulation of, access to, and reimbursement for regenerative medicine products, and any other issues related to the Alliance for Regenerative Medicine specifically.
Health Issues · 2026 Q2
Provide strategic counsel and advocate on issues related to medical device regulation, supply chains and trade
Tariff (miscellaneous tariff bills) · 2026 Q2
Provide strategic counsel and advocate on issues related to the Company's reimbursement and coding priorities.
Medical/Disease Research/Clinical Labs · 2026 Q2
Provide strategic counsel and advocate on issues related to health care legislative and regulatory issues.
Pharmacy · 2026 Q2
Provide strategic counsel and advocate on issues related to the Physician Fee Schedule
Medicare/Medicaid · 2026 Q2

Clients

$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 2 filings
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings14
2026 Q3
AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
RRlda.gov →
2026 Q2
INDUCTIVEHEALTH INFORMATICS
Q2lda.gov →
2026 Q2
NYU LANGONE HEALTH
Q2lda.gov →
2026 Q2
THE PROCTER & GAMBLE COMPANY
Q2lda.gov →
2026 Q2
AMERICAN SOCIETY OF GENE AND CELL THERAPY
Q2lda.gov →
2026 Q2
WALGREEN CO.
Q2lda.gov →
2026 Q2
TEXAS ESSENTIAL HEALTHCARE PARTNERSHIPS
Q2lda.gov →
2026 Q2
ALLIANCE FOR REGENERATIVE MEDICINE
Q2lda.gov →
2026 Q2
EDWARDS LIFESCIENCES LLC
Q2lda.gov →
2026 Q2
CURANA HEALTH, INC.
Q2lda.gov →
2026 Q2
GRADY HEALTH SYSTEM
Q2lda.gov →
2026 Q2
MONTANA HEALTH SOLUTIONS, INC.
Q2lda.gov →
2026 Q2
DEXCOM
Q2lda.gov →
2026 Q2
ADVANCED MEDICAL TECHNOLOGY ASSOCIATION
Q2lda.gov →